ESCCardiology2021Updated 2021
ESC/EACTS Guidelines for the Management of Valvular Heart Disease 2021
Published by European Society of Cardiology · 96 pages · Class I–II
Low-riskTAVI expansion
Class IIaTEER for sMR
MandatoryHeart Team
Summary
Free previewUpdated recommendations expand TAVI (TAVR) indications to lower-risk patients, with Heart Team decision mandatory. Transcatheter edge-to-edge repair (TEER) recommended for secondary MR in symptomatic patients with HFrEF. Anticoagulation strategy post-TAVI updated with VKA or NOAC depending on indication.
Valvular Heart DiseaseTAVIAortic stenosisMitral regurgitationTEERHeart Team
Key Recommendations
Evidence Grading & Drug Doses
What's New vs Previous Version
Implementation & Clinical Pearls
Full guideline access requires an account
Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.
Full guideline text with all recommendations
Evidence grades (Class I/II/III, Level A/B/C)
AI-generated summary and clinical pearls
Auto-logged as CPD/CME activity
Free plan includes 10 guideline reads per day · No credit card required